What are the differential diagnoses for a tree‑in‑bud appearance on chest CT?

Tree-in-Bud Pattern on Chest CT: Comprehensive Differential Diagnosis

The tree-in-bud pattern on chest CT most commonly represents infectious bronchiolitis, but you must systematically consider infectious, inflammatory, aspiration-related, immunologic, congenital, and malignant etiologies based on clinical context and distribution patterns.

Understanding the Pattern

The tree-in-bud appearance consists of small centrilobular nodules of soft-tissue attenuation connected to multiple branching linear structures originating from a single stalk 1. Pathologically, this correlates with plugging of small airways with mucus, pus, or fluid; dilated bronchioles; and bronchiolar wall thickening 2.

Primary Differential Diagnoses by Category

Infectious Causes (Most Common - 67.5% of cases)

The infectious etiology reflects the overall incidence of organisms in community-acquired versus hospital-acquired populations 3.

Mycobacterial Infections:

• Mycobacterium tuberculosis - Original description of this pattern; presents with centrilobular nodules and bronchial wall thickening in 38/52 patients (73%) 2
• Nontuberculous mycobacteria:
  • M. avium-intracellulare complex: 22/37 patients (59%) show tree-in-bud 2
  • M. kansasii: 27/33 patients (82%) demonstrate this pattern 2

Bacterial Infections:

• Mycoplasma pneumoniae: 44/52 patients (85%) with tree-in-bud and bronchial wall thickening 2
• Other bacterial pathogens causing community-acquired or hospital-acquired pneumonia 4, 3

Fungal Infections:

• Allergic bronchopulmonary aspergillosis: 6/9 patients (67%) with characteristic pattern 2
• Other fungal pathogens 1

Viral and Parasitic Infections:

• Various viral pneumonias 1
• Parasitic infections 1

Aspiration and Inhalation Disorders (10.4% of cases)

• Diffuse aspiration bronchiolitis: 12/13 patients (92%) demonstrate tree-in-bud with bronchial wall thickening 2
• Aspiration pneumonia 3
• Inhalation of toxic agents 4

Immunologic and Inflammatory Disorders

HTLV-1 Associated Disease:

• Human T-lymphotropic virus type 1 carriers: 88 patients with tree-in-bud pattern, 57/99 (58%) with bronchial wall thickening 2

Idiopathic Disorders:

• Diffuse panbronchiolitis: 12/12 patients (100%) show tree-in-bud and bronchial wall thickening 2
• Obliterative bronchiolitis 1

Connective Tissue Diseases:

• Churg-Strauss syndrome: 4/12 patients 2
• Microscopic polyangiitis: 27/48 patients 2
• Systemic lupus erythematosus: 7/8 patients 2
• Other connective tissue disorders 1

Hypersensitivity Pneumonitis:

• While HP can show centrilobular findings, it more commonly presents with ill-defined centrilobular nodules of ground-glass attenuation rather than classic tree-in-bud 5, 2

Malignant Causes (4-13.5% of cases)

Primary Lung Malignancy:

• Mucinous adenocarcinoma can mimic infectious tree-in-bud pattern 6
• Lung cancer: 13/326 patients (4%) in one series 3

Metastatic Disease:

• Neoplastic pulmonary emboli 1
• Other malignancies: 31/326 patients (9.5%) 3

Other Causes

• Congenital disorders 4, 1
• Drug-induced lung disease 5
• Immunodeficiency states 5
• Smoking-related lesions including respiratory bronchiolitis 5
• Environmental exposures and pneumoconiosis 5

Critical Distinguishing Features

Pattern Recognition for Diagnosis:

Classic Tree-in-Bud (suggests infection/aspiration):

• Centrilobular nodules with branching linear structures
• Bronchial wall thickening frequently present
• Correlates with airway plugging and bronchiolar inflammation 2

Ill-Defined Centrilobular Ground-Glass Nodules (suggests inflammatory/immunologic):

• Seen in hypersensitivity pneumonitis (15/15 patients) 2
• Metastatic calcification (4/4 patients) 2
• Respiratory bronchiolitis-associated ILD (8/8 patients) 2
• Represents peribronchiolar inflammation or hemorrhagic material deposition 2

Clinical Context Clues:

High-risk for malignancy when:

• Persistent tree-in-bud opacities unresponsive to antimicrobials 6
• Patient has smoking history or environmental exposures 6
• Mediastinal lymphadenopathy present 6

Favor infection when:

• Acute or subacute presentation
• Fever, productive cough, elevated inflammatory markers
• Response to antimicrobial therapy

Diagnostic Approach

When tree-in-bud pattern is identified:

1. Correlate with clinical presentation - acute vs. chronic, immunocompetent vs. immunocompromised
2. Assess distribution - unilateral vs. bilateral, upper vs. lower lobe predominance
3. Identify additional CT findings - bronchial wall thickening, ground-glass opacities, lymphadenopathy
4. If infectious etiology suspected - obtain appropriate cultures (sputum, BAL) and initiate empiric therapy
5. If unresponsive to antimicrobials or atypical features - proceed to bronchoscopy with BAL, brushing, and biopsy 6
6. In malignancy-suspicious cases - immunohistochemistry is essential for definitive diagnosis 6

Common Pitfalls

• Assuming all tree-in-bud patterns are infectious - malignancy accounts for up to 13.5% of cases 3
• Delaying tissue diagnosis in persistent cases - mucinous adenocarcinoma can perfectly mimic infection 6
• Confusing tree-in-bud with ground-glass centrilobular nodules - these represent different pathologic processes with distinct differential diagnoses 2
• Overlooking drug-induced or environmental causes - detailed exposure history is critical 5